Exposure to allopurinol and the risk of cataract extraction in elderly patients

被引:15
作者
Garbe, E
Suissa, S
LeLorier, J
机构
[1] Potsdam Inst Pharmacoepidemiol & Technol Assessme, D-14482 Potsdam, Germany
[2] Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[4] Univ Montreal, Ctr Hosp, Pharmacoepidemiol Unit, Montreal, PQ, Canada
关键词
D O I
10.1001/archopht.116.12.1652
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To determine whether exposure to allopurinol is associated with an increased risk of cataract extraction in elderly patients. Methods: We conducted a case-control study using data from the Quebec universal health insurance program for all elderly patients. The 3677 cases were patients with a cataract extraction between 1992 and 1994. The 21 868 controls were randomly selected among patients not diagnosed with cataract and matched to cases on the date of the extraction. We determined the odds ratio of cataract extraction according to the cumulative dose and duration of allopurinol use relative to nonusers, using conditional logistic regression analysis. The analysis was adjusted for the effects of age, sex, diabetes mellitus, hypertension, glaucoma, and ophthalmic and oral corticosteroid exposure. Results: A cumulative dose of allopurinol of more than 400 g or a duration of use of longer than 3 years were associated with an increased risk of-cataract extraction, with odds ratios of 1.82 (95% confidence interval [CI], 1.18-2.80) and 1.53 (95% CI, 1.12-2.08), respectively. No increase in risk was observed for lower cumulative doses or shorter exposure periods. Conclusion: Long-term administration of allopurinol increases the risk of cataract extraction in elderly patients.
引用
收藏
页码:1652 / 1656
页数:5
相关论文
共 29 条
[1]  
[Anonymous], 1999, International classification of diseases, clinical modification: Ninth revision, tenth edition
[2]   ULTRAVIOLET-LIGHT EXPOSURE AND RISK OF POSTERIOR SUBCAPSULAR CATARACTS [J].
BOCHOW, TW ;
WEST, SK ;
AZAR, A ;
MUNOZ, B ;
SOMMER, A ;
TAYLOR, HR .
ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (03) :369-372
[3]  
Bonomi L, 1989, Dev Ophthalmol, V17, P196
[4]   ALLOPURINOL USE AND THE RISK OF CATARACT FORMATION [J].
CLAIR, WK ;
CHYLACK, LT ;
COOK, EF ;
GOLDMAN, L .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (03) :173-176
[5]   SUNLIGHT, SKIN SENSITIVITY, AND SENILE CATARACT [J].
DOLEZAL, JM ;
PERKINS, ES ;
WALLACE, RB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (03) :559-568
[6]   Drug therapy - The management of gout [J].
Emmerson, BT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) :445-451
[7]   CATARACTS ASSOCIATED WITH ALLOPURINOL THERAPY [J].
FRAUNFELDER, FT ;
HANNA, C ;
DREIS, MW ;
COSGROVE, KW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (02) :137-140
[8]   DIABETES, GLAUCOMA, SEX, AND CATARACT - ANALYSIS OF COMBINED DATA FROM 2 CASE CONTROL STUDIES [J].
HARDING, JJ ;
EGERTON, M ;
VANHEYNINGEN, R ;
HARDING, RS .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1993, 77 (01) :2-6
[9]   DRUGS, INCLUDING ALCOHOL, THAT ACT AS RISK-FACTORS FOR CATARACT, AND POSSIBLE PROTECTION AGAINST CATARACT BY ASPIRIN-LIKE ANALGESICS AND CYCLOPENTHIAZIDE [J].
HARDING, JJ ;
VANHEYNINGEN, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1988, 72 (11) :809-814
[10]   Risk factors for age-related cataracts [J].
Hodge, WG ;
Whitcher, JP ;
Satariano, W .
EPIDEMIOLOGIC REVIEWS, 1995, 17 (02) :336-346